NCT06145711View on ClinicalTrials.gov

A Clinical Trial of Parkinson's Disease Treatment by HiPSCs Derived Dopaminergic Neural Precursor Cells

NARecruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 23, 2023

Primary Completion Date

December 22, 2025

Study Completion Date

December 22, 2025

Conditions
Parkinson's Disease
Interventions
OTHER

hiPSC-DAP

Using hiPSC-DAP for the treatment of the patients of Parkinson's diease

Trial Locations (2)

200120

RECRUITING

Shanghai East Hospital, Shanghai

Unknown

NOT_YET_RECRUITING

Shanghai East Hospital, Shanghai

All Listed Sponsors
lead

Shanghai East Hospital

OTHER